Poster Presentations
Poster sessions will occur in the Alumni Hall and Foyer of Victoria College
| PRESENTER NAME | POSTER TITLE | PRESENTATION DATE | POSTER NUMBER |
| Parker Grant | Assessing the convergent and divergent validity of three anhedonia measures in individuals with cannabis use disorder and major depressive disorder | Day 1, APRIL 30 | 1 |
| Julia Ryan | Effects of extended cannabis abstinence on verbal learning and memory in individuals with major depressive disorder and cannabis use disorder | Day 1, APRIL 30 | 2 |
| Maryam Sorkhou | The effects of extended cannabis abstinence in young adults with co-ocurring cannabis use disorder and major depression | Day 1, APRIL 30 | 3 |
| Cassie Cote | Synaptic density in mental health treatment-seeking youth with cannabis use disorder: A PET Study with [18F]SynVest-1 | Day 1, APRIL 30 | 4 |
| Christina Pereira | Endocannabinoid metabolism inversely correlated with alcohol use behaviours in individuals with social anxiety disorder: A [11C]CURB PET investigation | Day 1, APRIL 30 | 5 |
| Raesham Mahmood | Investigating the effects of nabilone on endocannabinoid metabolism in the human brain | Day 1, APRIL 30 | 6 |
| Hanan Idd | The endocannabinoid system in obsessive-compulsive disorder: A scoping review | Day 1, APRIL 30 | 7 |
| Grace Reynolds | The therapeutic relationship between cannabis use and ADHD: A systematic review | Day 1, APRIL 30 | 8 |
| Trinity Vey | Examining the relationship between cannabis usage and mental health among youth and young adults: A qualitative study of youth cannabis consumers and non-consumers | Day 1, APRIL 30 | 9 |
| Mikayla Lisi | Cannabis strain use among emerging adults: Associations with mood, motives, mental health, and cannabis consequences | Day 1, APRIL 30 | 10 |
| Camara Azubuike | Investigating the influence of ethnocultural identity on cannabis use among black Canadian emerging adults | Day 1, APRIL 30 | 11 |
| Natasha Manuel | The relationship between the frequency of and motivation for cannabis use with sexual functioning outcomes | Day 1, APRIL 30 | 12 |
| Tara Rosewall | Investigating the association between lifetime cannabis exposure and prostate cancer incidence: A single centre case-control study | Day 1, APRIL 30 | 13 |
| Adam Zaweel & Paulina Antwi | Dose-related effects of cannabis edibles on simulated driving performance | Day 1, APRIL 30 | 14 |
| Sampson Zhao | Association of driving with blood THC: A systematic review | Day 1, APRIL 30 | 15 |
| Christina Zakala | Detection of driving impairment "the morning after" last cannabis use in frequent smokers: A protocol | Day 1, APRIL 30 | 16 |
| Viviane Verdant | CAN-B cohort study: Preliminary analysis of cannabis consumption profile in pregnancy | Day 2, MAY 1 | 1 |
| Aurelie Faucher | Can-B cohort: The impacts of cannabis use during pregnancy on circulating endocannabinoids | Day 2, MAY 1 | 2 |
| Aurelie Faucher | Correlation between cannabis use in pregnant women and presence of urinary and blood phytocannabinoids | Day 2, MAY 1 | 3 |
| Jodi Anderson | Prevalence, practices, and attitudes of medicinal cannabis use in pediatrics | Day 2, MAY 1 | 4 |
| Jessica Overby | Development of an adverse event reporting tool for medical cannabis research | Day 2, MAY 1 | 5 |
| Danny Puente Proano | Endocanna-Health project: A translational approach to innovate clinicians training on cannabinoid-based therapies for chronic pain management | Day 2, MAY 1 | 6 |
| Anna Mouzenian | Feasibility and determinants of adherence to wearable technology in substance use disorders | Day 2, MAY 1 | 7 |
| Derek Robertson | Microglial and synaptic effects of delta-9-tetra-hydrocannabinol (THC) in adolescent cortex | Day 2, MAY 1 | 8 |
| Rebecca Przy | Exploring the impact of prenatal vaporized tetrahydrocannabinol (THC) exposure on neurogenesis and synaptic plasticity in the hippocampus | Day 2, MAY 1 | 9 |
| Sierra D'Amico | Impact of cannabis smoke exposure in utero on the development of enteric glia | Day 2, MAY 1 | 10 |
| Keemo Delos Santos | Oral delivery of delta-9-tetrahydrocannabinol has pain-modifying effects in mouse models of knee osteoarthritis | Day 2, MAY 1 | 11 |
| Piotr Kurzyna | Cannabidiolic acid as a modulator of intracellular lipid transport in the liver of rats with induced MASLD | Day 2, MAY 1 | 12 |
| Lola Zovko | Effects of endocannabinoid modulation in an acute mouse model of Parkinson's disease | Day 2, MAY 1 | 13 |
| Giacomo Trottier | In vitro signaling profiles of cannabis products allow to infer their in vivo analgesic potential | Day 2, MAY 1 | 14 |
| Cameron MacLeod | Use of a cannabigerol and cannabidiol formulation on behaviour and motor coordination in the C57BL/6 mouse | Day 2, MAY 1 | 15 |
| Catharine Mielnik | High 2-AG potentiates amphetamine-induced dopamine levels; Prolonging dopamine time-course and increasing peak levels. | Day 2, MAY 1 | 16 |
| Claudia Lutelmowski | Orthosteric and allosteric negative CB1-R modulation in hyperdopaminergic states | Day 2, MAY 1 | 17 |
| Theodor Zaharia | Refinement of allosteric modulators at the type 1 cannabinoid receptor | Day 2, MAY 1 | 18 |
| Haley Andersen | CB1 receptor-driven, GIRK channel response to novel allosteric modulators | Day 2, MAY 1 | 19 |